説明
Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation.
Figure 14
ChartSource Paper
Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization.Cite This Figure
![Figure 14: Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation.]() > Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." *International journal of molecular sciences*, 2022. PMID: [35955845](https://pubmed.ncbi.nlm.nih.gov/35955845/)
<figure> <img src="" alt="Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation." /> <figcaption>Figure 14. Summary comparison of anti-aggregation efficacy metrics for curcumin versus RuCurcumin across all experimental assays, highlighting the therapeutic advantage of metal complexation.<br> Source: Massimiliano Cuccioloni et al. "Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthen." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35955845/">35955845</a></figcaption> </figure>